156 related articles for article (PubMed ID: 38317244)
1. Long noncoding RNA XIST promotes cell proliferation and migration in diabetic foot ulcers through the miR-126-3p/EGFR axis.
Hong W; Xiong Z; Wang X; Liao X; Liu M; Jiang Z; Min D; Li J; Guo G; Fu Z
Diabetol Metab Syndr; 2024 Feb; 16(1):35. PubMed ID: 38317244
[TBL] [Abstract][Full Text] [Related]
2. LncRNA XIST promotes extracellular matrix synthesis, proliferation and migration by targeting miR-29b-3p/COL1A1 in human skin fibroblasts after thermal injury.
Cao W; Feng Y
Biol Res; 2019 Sep; 52(1):52. PubMed ID: 31540582
[TBL] [Abstract][Full Text] [Related]
3. Peptide RL-QN15 promotes wound healing of diabetic foot ulcers through p38 mitogen-activated protein kinase and smad3/miR-4482-3p/vascular endothelial growth factor B axis.
Sun D; Guo K; Liu N; Li Y; Li Y; Hu Y; Li S; Fu Z; Wang Y; Wu Y; Zhang Y; Li J; Li C; Wang Z; Kang Z; Sun J; Wang Y; Yang X
Burns Trauma; 2023; 11():tkad035. PubMed ID: 38026443
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA XIST knockdown suppresses the growth of colorectal cancer cells via regulating microRNA-338-3p/PAX5 axis.
Li W; He Y; Cheng Z
Eur J Cancer Prev; 2021 Mar; 30(2):132-142. PubMed ID: 32826710
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
6. LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1/2 expression.
Liu L; Jiang H; Pan H; Zhu X
J Int Med Res; 2021 May; 49(5):3000605211016211. PubMed ID: 34018840
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA X-Inactive-Specific Transcript Promotes the Secretion of Inflammatory Cytokines in LPS Stimulated Astrocyte Cell Via Sponging miR-29c-3p and Regulating Nuclear Factor of Activated T cell 5 Expression.
Zhang M; Yang H; Chen Z; Hu X; Wu T; Liu W
Front Endocrinol (Lausanne); 2021; 12():573143. PubMed ID: 33776905
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of lncRNA XIST promotes proliferation and differentiation, limits apoptosis of osteoblasts through regulating miR-203-3p/ZFPM2 axis.
Niu S; Xiang F; Jia H
Connect Tissue Res; 2021 Jul; 62(4):381-392. PubMed ID: 32326773
[No Abstract] [Full Text] [Related]
9. LncRNA XIST promotes neovascularization in diabetic retinopathy by regulating miR-101-3p/VEGFA.
Fu W; Ye Y; Hu F
Arch Endocrinol Metab; 2024 May; 68():e230097. PubMed ID: 38739522
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
Zhao CH; Bai XF; Hu XH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
[TBL] [Abstract][Full Text] [Related]
11. lncRNA XIST/miR‑129‑2‑3p axis targets CCP110 to regulate the proliferation, invasion and migration of endometrial cancer cells.
Chen S; Liang Y; Shen Y; Wang X
Exp Ther Med; 2023 Apr; 25(4):159. PubMed ID: 36911384
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
Liu X; Xie S; Zhang J; Kang Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
[No Abstract] [Full Text] [Related]
13. Downregulating LncRNA XIST attenuated contrast-induced nephropathy injury via regulating miR-133a-3p/NLRP3 axis.
Liu X; Song W; Zhang X; Long F; Yin J; He X; Lv L
J Thromb Thrombolysis; 2021 Aug; 52(2):440-453. PubMed ID: 33387208
[TBL] [Abstract][Full Text] [Related]
14. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
15. LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.
Xia X; Li Z; Li Y; Ye F; Zhou X
J Gynecol Oncol; 2022 Nov; 33(6):e81. PubMed ID: 36335987
[TBL] [Abstract][Full Text] [Related]
16. LncRNA XIST Protects Against Polycystic Ovary Syndrome via the Regulation of miR-212-3p/RASA1 Axis.
Xu X; Yin C; Dong B; Li Y; Liu S; Chen J
Biochem Genet; 2024 Apr; ():. PubMed ID: 38609670
[TBL] [Abstract][Full Text] [Related]
17. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis.
Wang YP; Li HQ; Chen JX; Kong FG; Mo ZH; Wang JZ; Huang KM; Li XN; Yan Y
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3190-3203. PubMed ID: 32271437
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
20. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.
Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ
Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
